Dr. Jinquan Sun, co-Founder of Convergen tina wanng

Convergen Raises $10M Seed to Advance TrimTAC Platform for Targeted Protein Degradation in Neurodegenerative Diseases – News

Biotech startup Convergen has closed $10 million in Seed funding to accelerate development of its TrimTAC platform, a next-generation targeted protein degradation (TPD) technology designed to selectively clear pathogenic protein aggregates. The round was led by Qiming Venture Partners, a leading global venture capital firm specializing in healthcare and life sciences. Convergen’s proprietary TrimTAC platform…

Read More
Corma Co-Founders: (from left to right) Samuel Bismut, Héloïse Rozès, & Nikolai Fomm

Corma Raises €3.5M Seed Round to Tackle Software Sprawl with AI-Powered SaaS Management – News

SaaS management startup Corma has raised €3.5 million in Seed funding to expand its AI-driven platform that helps companies control software sprawl, cut costs, and optimize internal application use. The round was led by XTX Ventures, with participation from Tuesday Capital, Kima Ventures, 50 Partners, and Olympe Capital. Founded in 2023, Corma aims to address…

Read More
Eduardo-Indacochea

Scowtt Raises $12M Series A to Advance Predictive, Cost-Efficient AI for Enterprise Performance Marketing

Advertising intelligence startup Scowtt has secured $12 million in Series A funding as it moves to redefine performance marketing with predictive AI models that run on advertisers’ own first-party CRM data. The round was led by Inspired Capital, with additional participation from LiveRamp Ventures, Angeles Investors and Angeles Ventures. Founded in 2024, Scowtt sits at…

Read More
chemlex

ChemLex Secures USD 45M to Establish AI-Powered Autonomous Chemistry Headquarters in Singapore

AI-for-science pioneer ChemLex has raised USD 45 million and selected Singapore as the site of its global headquarters and self-driving laboratory, marking a decisive expansion for the fast-growing deep-tech company reshaping chemical and pharmaceutical R&D. Founded in 2022, ChemLex develops autonomous, AI-powered chemistry systems designed to compress months of molecule discovery into weeks or even…

Read More
Founders-1920x1080 Bryon Hargis, CEO and Co-Founder of Castelion

Castelion’s $350 Million Raise Accelerates Cost-Efficient Hypersonic Weapons Buildout

Hypersonic weapons developer Castelion has secured $350 million in Series B funding, strengthening U.S. efforts to produce cost-efficient hypersonic systems at industrial scale as geopolitical competition with China and Russia intensifies. The round was led by Altimeter Capital and Lightspeed Venture Partners, with additional participation from Lavrock Ventures, Andreessen Horowitz, General Catalyst, First In, Space…

Read More